ESTHER HERVAS ROMERO

Dr. ESTHER HERVAS ROMERO


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
RSRamon Sagarra
Ramon Sagarra
ERESTHER HERVAS ROMERO
ESTHER HERVAS ROMERO
RBReyes Blasco
Reyes Blasco
ECEugeni García Curto
Eugeni García Curto
(1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored.

15 November 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
PRPedro ROMERO-AROCA
Pedro ROMERO-AROCA
BMBaget-Bernaldiz Marc
Baget-Bernaldiz Marc
RSRamon Sagarra
Ramon Sagarra
ERESTHER HERVAS ROMERO
ESTHER HERVAS ROMERO
RBReyes Blasco
Reyes Blasco
ECEugeni García Curto
Eugeni García Curto
(1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM) and the COVID-19 pandemic has affected screening programmes. The aim of present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our Health Care Area (HCA); (2) Methods: A retrospective study of patients with DM who had attended the DR screening programme between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first months of the pandemic. Incidence of mild and moderate DR remained stable throughout the study, and we observed a little increase in severe-DR, proliferative-DR and neovascular glaucoma, during 2021 and 2022. (4) Conclusions: The COVID-19 pandemic caused a reduction in the number of patients screened for DM, although its effect on DR seems limited, with a similar number of patients with DR throughout 2015 to 2022, despite the number of patients with severe-DR and proliferative-DR increased in 2021 and 2022.